⚠️ High Alert Medication

Milrinone Infusion

Syringe pump continuous infusion preparation (200 mcg/mL), inodilator titration, renal dose adjustment, and hypotension surveillance protocol.

Syringe Pump Infusion Preparation (Standard Concentration)

Vial Presentation 10 mL vial (1 mg/mL of milrinone lactate)
Milrinone Dose 10 mg (10 mL = one 10 mL vial)
Compatible Diluent 40 mL of D5W or 0.9% Sodium Chloride (NS)
Final Syringe Volume 50 mL
Final Concentration 200 mcg/mL (0.2 mg/mL)
Stability 24 hours at room temperature

Materials Required

  • Milrinone vial 1 mg/mL (10 mL) × 1
  • 60 mL Luer-lock syringe
  • 0.9% Sodium Chloride (NS) or 5% Dextrose (D5W)
  • Sterile drawing-up needle / filter needle
  • Dedicated syringe pump infusion label
  • Extension line (100 cm)
  • Alcohol chlorhexidine swabs

Preparation Procedure (Aseptic Non-Touch Technique)

  1. Verification: Verify the written physician order, patient identity, body weight, clinical indication, and most recent serum creatinine / creatinine clearance.
  2. Pre-Infusion Checks: Confirm serum potassium and magnesium are within range, and that intravascular volume is adequate.
  3. Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
  4. Vial Check: Check the milrinone vial for:
    • Correct drug and strength, milrinone lactate (1 mg/mL)
    • Expiry date
    • Container integrity, clarity, and absence of precipitate or discoloration
  5. Withdrawal: Withdraw 10 mL from the vial into a 60 mL Luer-lock syringe (Total milrinone drawn: 10 mL = 10 mg milrinone).
  6. Dilution: Add 40 mL of 0.9% Sodium Chloride or D5W to a final volume of 50 mL.
  7. Mixing: Gently invert the syringe several times to ensure uniform mixing.
  8. Visual Inspection: Inspect solution to ensure it is clear, colorless to pale yellow, and free of visible particles.
  9. Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
  10. Syringe Pump Setup: Prime the extension set and install into the syringe pump.

🔒 Lumen Policy: Milrinone forms an immediate precipitate with furosemide (and bumetanide) in the same line. It is also incompatible with imipenem and procainamide. Infuse via a dedicated lumen, and never give loop diuretics through the milrinone line.

⚠️ Line Access: Milrinone is not a vesicant and may be infused via a peripheral or central line, with routine site checks.

Mechanism & Hemodynamic Profile

Milrinone inhibits phosphodiesterase-3, raising intracellular cAMP in myocardium and vascular smooth muscle. Because it acts downstream of the β-receptor, it remains effective in patients on β-blockers or with β-receptor down-regulation.

Cardiac Effect

↑ Contractility & Relaxation
  • Positive inotropy and improved diastolic relaxation (lusitropy)
  • Less rise in heart rate than dobutamine

Vascular Effect

↓ SVR & ↓ PVR
  • Systemic and pulmonary vasodilation reduce afterload
  • Useful in right ventricular failure with raised pulmonary pressures

Pharmacokinetic Caution

Long Half-Life (~2–3 hr)
  • Renally cleared; half-life lengthens markedly in kidney impairment
  • Hypotension may persist for hours after stopping the infusion

Administration & Titration

Recommended Dosing Parameters

  • Administration Route: Administer via syringe pump; dedicated lumen preferred.
  • Loading Dose (Optional): 50 mcg/kg over 10 minutes. Often omitted in the ICU because of the risk of hypotension; give only on explicit clinician order.
  • Recommended Starting Dose: 0.25 to 0.375 mcg/kg/min (titrate infusion to achieve desired hemodynamic result).
  • Typical ICU Titration Range: 0.25 to 0.75 mcg/kg/min.
  • Titration Interval: Adjust slowly (every 2 to 4 hours or longer), because steady state takes several hours to reach.
  • Maximum Dose: 0.75 mcg/kg/min, reduced according to renal function (see table).
  • Hypovolemia: Correct intravascular volume depletion before initiation.
  • Syringe Continuity: Do not allow the infusion to run out. A syringe can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
  • Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes discoloured, cloudy, or contaminated.

Hemodynamic Monitoring Requirements

  • Monitor arterial blood pressure continuously (invasive arterial line preferred), especially during any loading dose.
  • Monitor heart rate and continuous ECG for ventricular ectopy, ventricular tachycardia, and atrial fibrillation.
  • Track cardiac output indices where available (echocardiography, ScvO2, cardiac output monitoring).
  • Monitor serum creatinine and urine output daily; adjust the dose if renal function changes.
  • Check serum potassium and magnesium; correct deficits to reduce arrhythmia risk.
  • Check platelet count periodically for thrombocytopenia.

Clinical Cautions

  • Hypotension: Often requires concurrent noradrenaline to maintain perfusion pressure.
  • Outflow Obstruction: Avoid in severe obstructive aortic or pulmonic valve disease and hypertrophic obstructive cardiomyopathy.
  • Atrial Flutter / Fibrillation: May increase ventricular response rate; ensure rate control.
  • Acute Myocardial Infarction: Not recommended in the acute phase.

Renal Dose Adjustment

Milrinone is excreted mainly unchanged in the urine. Reduce the maximum infusion rate according to creatinine clearance:

Creatinine Clearance
(mL/min/1.73 m²)
Maximum Infusion Rate
(mcg/kg/min)
> 500.75 (no adjustment)
500.43
400.38
300.33
200.28
100.23
50.20

Renal replacement therapy and rapidly changing kidney function require individualized dosing under intensivist and pharmacist guidance.

Hypotension & Arrhythmia Response Protocol

Milrinone is not a vesicant; its principal acute hazards are hypotension and arrhythmias. Unlike short-acting agents, its effects do not resolve within minutes of stopping.

Expected Response

  • Mean arterial pressure within prescribed target
  • Improving cardiac output and perfusion markers
  • No new ventricular ectopy or arrhythmia
  • Adequate urine output

Hypotension or New Arrhythmia:

  1. Reduce or STOP infusion as directed.
  2. Notify clinician promptly; a vasopressor or fluid bolus may be needed on clinician order.
  3. Check potassium, magnesium, and 12-lead ECG for arrhythmias.
  4. Continue close monitoring for several hours, longer in renal impairment.
  5. Document event in patient clinical record.

Milrinone Infusion Rate Chart (200 mcg/mL)

Shows equivalent dose in mcg/kg/min for a given pump rate (mL/hr) across patient weights. Check the renal adjustment table before using upper-range rates.

Rate
(mL/hr)
Weight (Kg) and Dose (mcg/kg/min)
40 kg 45 kg 50 kg 55 kg 60 kg 65 kg 70 kg 75 kg 80 kg 85 kg 90 kg 95 kg 100 kg
10.080.070.070.060.060.050.050.040.040.040.040.040.03
20.170.150.130.120.110.100.100.090.080.080.070.070.07
30.250.220.200.180.170.150.140.130.120.120.110.110.10
40.330.300.270.240.220.210.190.180.170.160.150.140.13
50.420.370.330.300.280.260.240.220.210.200.190.180.17
60.500.440.400.360.330.310.290.270.250.240.220.210.20
70.580.520.470.420.390.360.330.310.290.270.260.250.23
80.670.590.530.480.440.410.380.360.330.310.300.280.27
90.750.670.600.550.500.460.430.400.380.350.330.320.30
100.830.740.670.610.560.510.480.440.420.390.370.350.33
110.920.810.730.670.610.560.520.490.460.430.410.390.37
121.000.890.800.730.670.620.570.530.500.470.440.420.40
131.080.960.870.790.720.670.620.580.540.510.480.460.43
141.171.040.930.850.780.720.670.620.580.550.520.490.47
151.251.111.000.910.830.770.710.670.620.590.560.530.50
161.331.191.070.970.890.820.760.710.670.630.590.560.53
171.421.261.131.030.940.870.810.760.710.670.630.600.57
181.501.331.201.091.000.920.860.800.750.710.670.630.60
191.581.411.271.151.060.970.900.840.790.750.700.670.63
201.671.481.331.211.111.030.950.890.830.780.740.700.67
211.751.561.401.271.171.081.000.930.880.820.780.740.70
221.831.631.471.331.221.131.050.980.920.860.810.770.73
231.921.701.531.391.281.181.101.020.960.900.850.810.77
Within usual range (≤ 0.75 mcg/kg/min) Exceeds 0.75 mcg/kg/min maximum

Infusion Conversion (Solution Concentration 200 mcg/mL)

Standard equations for a 200 mcg/mL solution (10 mg in 50 mL):

Infusion Rate (mL/hr):

Rate (mL/hr) = [ Dose (mcg/kg/min) × Weight (kg) × 60 ] / 200

Shortcut: Rate = Dose × Weight × 0.3
Infusion Dose (micrograms/kg/minute):

Dose (mcg/kg/min) = [ Rate (mL/hour) × Concentration (200 mcg/mL) ] / [ Weight (kg) × 60 ]
Loading Dose (if ordered):

Volume (mL) = 50 mcg/kg × Weight (kg) / 200 = 0.25 mL/kg, given over 10 minutes

'Shortcut' example: 70 kg patient at 0.5 mcg/kg/min → 0.5 × 70 × 0.3 = 10.5 mL/hr. A loading dose for the same patient would be 17.5 mL over 10 minutes (105 mL/hr).

© criticalcareinsights.com. All rights reserved. For clinical reference and educational use only.